These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30318577)

  • 21. Endocan, TGF-beta, and ADMA as Risk Factors for Endothelial Dysfunction and Possible Vascular Disease in Patients with Subclinical Hypothyroidism.
    Arpaci D; Karakece E; Tocoglu AG; Ergenc H; Gurol G; Ciftci IH; Tamer A
    Ann Clin Lab Sci; 2016 Dec; 46(6):601-607. PubMed ID: 27993872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory and endothelial markers in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Alexandraki K; Piperi C; Protogerou A; Katsikis I; Paterakis T; Lekakis J; Panidis D
    Eur J Clin Invest; 2006 Oct; 36(10):691-7. PubMed ID: 16968464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.
    Piouka A; Farmakiotis D; Katsikis I; Macut D; Gerou S; Panidis D
    Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E238-43. PubMed ID: 18957615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal serum endocan concentrations are elevated in patients with preterm premature rupture of membranes.
    Ovayolu A; Ovayolu G; Karaman E; Yuce T; Turgut A; Bostancıeri N
    J Perinat Med; 2019 Jul; 47(5):510-515. PubMed ID: 30875331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome?
    Soares GM; Vieira CS; Martins WP; Franceschini SA; dos Reis RM; Silva de Sá MF; Ferriani RA
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):406-11. PubMed ID: 19094071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Relationship Between Serum Endocan Level and Aortic Elastic Properties in Patients With Newly Diagnosed Essential Hypertension.
    Çelik M; Sökmen E; Sivri S; Uçar C; Nar R; Erer M
    Angiology; 2019 Aug; 70(7):662-668. PubMed ID: 30630336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of circulating betatrophin concentrations in lean glucose-tolerant women with polycystic ovary syndrome.
    Erol O; Özel MK; Ellidağ HY; Toptaş T; Derbent AU; Yılmaz N
    J Obstet Gynaecol; 2017 Jul; 37(5):633-638. PubMed ID: 28319674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The predictive effect of inflammatory markers and lipid accumulation product index on clinical symptoms associated with polycystic ovary syndrome in nonobese adolescents and younger aged women.
    Tola EN; Yalcin SE; Dugan N
    Eur J Obstet Gynecol Reprod Biol; 2017 Jul; 214():168-172. PubMed ID: 28535403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study.
    Orio F; Palomba S; Spinelli L; Cascella T; Tauchmanovà L; Zullo F; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3696-701. PubMed ID: 15292291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome.
    Guedikian AA; Lee AY; Grogan TR; Abbott DH; Largaespada K; Chazenbalk GD; Dumesic DA
    Fertil Steril; 2018 Mar; 109(3):508-515. PubMed ID: 29428312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Predictive Role of Serum Cystatin C Levels in Polycystic Ovary Syndrome in Adolescents.
    Çınar M; Aksoy RT; Güzel Aİ; Tokmak A; Çandar T; Taşçı Y
    J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):353-6. PubMed ID: 26740281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome.
    Zueff LF; Martins WP; Vieira CS; Ferriani RA
    Ultrasound Obstet Gynecol; 2012 Mar; 39(3):341-7. PubMed ID: 21898634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocan: a novel predictor of endothelial dysfunction in obstructive sleep apnea syndrome.
    Kanbay A; Ceylan E; Köseoğlu Hİ; Çalışkan M; Takir M; Tulu S; Telci Çaklılı O; Köstek O; Erek A; Afsar B
    Clin Respir J; 2018 Jan; 12(1):84-90. PubMed ID: 27116287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
    Pinola P; Puukka K; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Lindén Hirschberg A; Ravn P; Skovsager Andersen M; Glintborg D; Mellembakken JR; Ruokonen A; Tapanainen JS; Morin-Papunen LC
    Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
    Verit FF
    Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular risk in young women with polycystic ovary and polycystic ovary syndrome.
    Battaglia C; Mancini F; Cianciosi A; Busacchi P; Facchinetti F; Marchesini GR; Marzocchi R; de Aloysio D
    Obstet Gynecol; 2008 Feb; 111(2 Pt 1):385-95. PubMed ID: 18238977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Periodontal status and high-sensitivity C-reactive protein levels in polycystic ovary syndrome with and without medical treatment.
    Porwal S; Tewari S; Sharma RK; Singhal SR; Narula SC
    J Periodontol; 2014 Oct; 85(10):1380-9. PubMed ID: 24592911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome.
    Cascella T; Palomba S; De Sio I; Manguso F; Giallauria F; De Simone B; Tafuri D; Lombardi G; Colao A; Orio F
    Hum Reprod; 2008 Jan; 23(1):153-9. PubMed ID: 18024952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.